This company listing is no longer active
Cyclacel Pharmaceuticals マネジメント
マネジメント 基準チェック /24
We currently do not have sufficient information about the CEO.
主要情報
Spiro Rombotis
最高経営責任者
US$661.0k
報酬総額
| CEO給与比率 | 84.7% |
| CEO在任期間 | 26.6yrs |
| CEOの所有権 | 2.2% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 7.5yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$25m |
| Jun 30 2023 | n/a | n/a | -US$24m |
| Mar 31 2023 | n/a | n/a | -US$23m |
| Dec 31 2022 | US$764k | US$546k | -US$21m |
| Sep 30 2022 | n/a | n/a | -US$19m |
| Jun 30 2022 | n/a | n/a | -US$19m |
| Mar 31 2022 | n/a | n/a | -US$20m |
| Dec 31 2021 | US$1m | US$531k | -US$19m |
| Sep 30 2021 | n/a | n/a | -US$20m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$1m | US$531k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | -US$8m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | US$1m | US$531k | -US$8m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | n/a | n/a | -US$8m |
| Dec 31 2018 | US$753k | US$531k | -US$7m |
| Sep 30 2018 | n/a | n/a | -US$8m |
| Jun 30 2018 | n/a | n/a | -US$14m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$776k | US$531k | -US$15m |
報酬と市場: Spiro's total compensation ($USD661.05K) is above average for companies of similar size in the German market ($USD404.23K).
報酬と収益: Spiro's compensation has been consistent with company performance over the past year.
CEO（最高経営責任者
Spiro Rombotis (64 yo)
26.6yrs
在職期間
US$661,049
報酬
Mr. Spiro George Rombotis has been President of Cyclacel Pharmaceuticals Inc. (formerly, Cyclacel Pharmaceuticals, Inc. (formerly known as Cyclacel Group plc)) since August 1997 and has been its Founding C...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 18yrs | US$661.05k | 2.19% € 64.5k | |
| Executive VP of Finance | 18yrs | US$352.62k | 1.19% € 35.0k | |
| Chief Medical Officer & Director | 3.3yrs | US$101.00k | 0.096% € 2.8k | |
| Independent Director | 9.5yrs | US$116.50k | 0.32% € 9.3k | |
| Independent Chairman | 18yrs | US$155.50k | 0.31% € 9.1k | |
| Independent Director | 3.3yrs | US$95.49k | 0.32% € 9.3k | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Vice Chairman | 5.5yrs | US$130.75k | 0.31% € 9.1k | |
| Independent Director | 1.8yrs | US$85.49k | 0.17% € 4.9k |
7.5yrs
平均在職期間
67yo
平均年齢
経験豊富なボード: UXI's board of directors are considered experienced (7.5 years average tenure).